GNS Healthcare Blog

GNS Healthcare Primary Blog

By December 31, 1969

GNS Healthcare Blog

Taking the Plunge: From ALS Ice Bucket Challenge to ALS Research with AI and Robust Data

If you drove around Boston in the summer of 2014, you wouldn’t be surprised to see individuals on their lawns, driveways, or in their back yards dumping buckets of ice water over their heads. The chilly act was part of a challenge that encouraged participants to film their icy shower, post it to social media, and nominate others to do the same. The nominee had 24 hours to comply or donate money to The ALS Association. Most people did both and the videos went viral, spreading across the country and, eventually, the world.

The ALS Ice Bucket Challenge was the brainchild of former Boston...

Read More

Real World Evidence: How It's Changing the Way Drugs are Developed and Valued

In the summer of 1996, two new prescription drugs, containing fenfluramine and phentermine, hit the market promising an easy way to lose weight. Use of the products skyrocketed and by mid 1997, almost two million people were taking them¹.

Just over a year later, in September of 1997, both products were abruptly pulled off the market amid growing concerns that use of the drugs may cause serious heart problems. The FDA found evidence that nearly one-third of those taking the drugs might develop a rare form of heart valve damage that could weaken the heart. Three deaths were linked to the use...

Read More

When Personalized Medicine Becomes Personal: Using AI to Fight Migraines

Imagine living with pain every day—when a four or five on a ten-point scale is a good day and eight or nine amounts to about a third of your days. Imagine not being able to do the thing you love – travel - because of noises, lights, smells, weather, and sleeping conditions. No more visits to the beach because of heat and bright sunlight. Cancelled plans, countless visits to doctors and emergency rooms, and trying to exist in a controlled environment of low light and minimal noise.

That’s the life my sister Nawarh lives – a life trying to cope with chronic migraines. And it breaks my heart.

Read More

Fear versus Promise: The Conversation Continues Around AI

There is a wide and varied mix of opinions when it comes to artificial intelligence (AI). Peruse just about any publication and there’s likely to be an article or two on how AI will transform the way we live for the better or conversely how it is sure to overtake our lives in unimaginable ways.

Adding to the confusion, you have technology visionaries like Elon Musk saying, “I’m close to artificial intelligence (AI) and it scares the hell out of me”. Or Bill Gates calling AI “our biggest existential threat.”1  Given those impressions, it’s no wonder that many people today still fear the...

Read More

Talent, Data, and Tech: An Inclusive Approach to Drug Development

Interest in applying artificial intelligence and machine learning to healthcare has reached a pinnacle. Every day there are a slew of new articles and reports discussing the various ways that algorithms can transform the industry and there are many interesting technologies being developed and deployed—from digital health technologies that aim to make care delivery more patient-centric to machines that use image recognition to identify tumors before the human eye can see them.

A big area of potential growth for the use of AI is in precision medicine— the ability to customize the treatment...

Read More

All AI Is Not Equal: Why Cause and Effect is Crucial for Healthcare

Judea Pearl is not happy.

One of the pioneers of Artificial Intelligence in the 1980’s, Pearl said in a recent interview in The Atlantic that the field of AI is stuck in a world of reasoning by association and probabilistic predictions. Pearl thinks too many people are deploying AI to overcome uncertainty – predicting what will happen next by association rather than leveraging the power of the technology to deal with cause and effect. He goes on to say that AI and machine learning need to move more aggressively to evaluate interventions and causal models to gain true value1.

Healthcare...

Read More

In Honor of the 4th – A Look Back at How Far Healthcare Has Come

Healthcare and the practice of medicine has certainly come a long way since the founding of the United States in 1776. In honor of the 242nd birthday of the U.S., we thought it would be interesting to see how far we have come since our nation’s birthday.  Check out some of the major medical milestones, contributions of American scientists and relish your luck in being born during the modern medical era.

Read More

Optimizing Drug R&D: 3 Strategies to Embrace

Biopharma continues to look for ways to streamline the drug development process. With costs of bringing a drug to market now reaching $2.7 billion and the timeline stretching to nearly a decade, stakeholders across the healthcare continuum are clamoring for a faster, less expensive method. 

The drug research and development process is well established and has remained largely unchanged over the past few decades and for good reason – it works. The methodology biopharma has followed has given the world many effective drugs which are both improving the quality of life for patient as well as...

Read More

3 Keys to Building a Proactive Healthcare System using AI

The U.S. health systems ranks 37th out of 191 countries in overall efficiency according to a recent ranking by the World Health Organization. WHO’s calculation includes a variety of indicators including population health, responsiveness, and fairness in financing and financial risk protection1.

The U.S ranks 43rd in life expectancy (79.7 years) behind other developed nations like Japan (84.74), Canada (81.76) and Germany (80.57)2. The U. S. does rank first in one category – total health expenditures, with an average per capita cost of $10,384, nearly twice the comparable country average of...

Read More

Location, Location, Location: AI Identifies Tumor Sidedness as Key Indicator of Progression in Metastatic Colorectal Cancer

Location matters, especially when it comes to tumors in colon cancer. The issue of “sidedness” – whether tumors are located on the right or left side of the intestine – and what impact that has on the progression of metastatic colorectal cancer (CRC) has been a topic of discussion in the clinical community for several years. A complete understanding of sidedness has not been well understood by researchers and clinicians. Is sidedness an independent driver, confounded by other factors, or a simply a surrogate for other determinants?  By leveraging artificial intelligence (AI) and causal...

Read More

Subscribe to the GNS Blog

Recent Posts:

Twitter